ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 118 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q3 2022. The put-call ratio across all filers is 0.53 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $370,000 | -5.9% | 24,948 | +0.0% | 0.00% | 0.0% |
Q2 2022 | $393,000 | -41.5% | 24,937 | +0.0% | 0.00% | -33.3% |
Q1 2022 | $672,000 | -27.1% | 24,936 | +0.0% | 0.00% | -25.0% |
Q4 2021 | $922,000 | -22.6% | 24,925 | +0.0% | 0.00% | -33.3% |
Q3 2021 | $1,191,000 | +41.3% | 24,920 | 0.0% | 0.01% | +50.0% |
Q2 2021 | $843,000 | -18.1% | 24,920 | -0.0% | 0.00% | -33.3% |
Q1 2021 | $1,029,000 | -9.7% | 24,925 | -5.1% | 0.01% | -14.3% |
Q4 2020 | $1,139,000 | -6.5% | 26,266 | -7.5% | 0.01% | -12.5% |
Q3 2020 | $1,218,000 | -12.0% | 28,396 | -4.1% | 0.01% | -20.0% |
Q2 2020 | $1,384,000 | +244.3% | 29,600 | 0.0% | 0.01% | +233.3% |
Q1 2020 | $402,000 | +24.8% | 29,600 | 0.0% | 0.00% | +50.0% |
Q4 2019 | $322,000 | +5.9% | 29,600 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $304,000 | +17.8% | 29,600 | +8.4% | 0.00% | 0.0% |
Q2 2019 | $258,000 | – | 27,300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SEVEN EIGHT CAPITAL, LP | 46,819 | $2,031,000 | 0.47% |
Orbimed Advisors | 1,206,886 | $49,844,000 | 0.47% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 25,000 | $1,033,000 | 0.40% |
ARK Investment Management | 3,331,889 | $137,607,000 | 0.27% |
FEDERATED HERMES, INC. | 3,203,000 | $132,284,000 | 0.26% |
MGO ONE SEVEN LLC | 26,990 | $1,114,000 | 0.19% |
Koss-Olinger Consulting, LLC | 20,000 | $826,000 | 0.14% |
Jump Financial, LLC | 35,400 | $1,462,000 | 0.14% |
Graham Capital Management, L.P. | 74,262 | $3,067,000 | 0.14% |
New England Research & Management, Inc. | 6,005 | $248,000 | 0.14% |